Parallel progression has been demonstrated so far in human epidermal growth factor receptor 2 (Her-2)-positive tumors and shows that dissemination of cancer cells occurs early on before the primary tumor becomes clinically evident (the first step of metastasis takes place at the same time the primary tumor develops) [5]. Here, ERBB2 is linked to neoplasm.